Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoid Tumor
×
Everolimus
×
Clear all
Filters
3
NCT05477576
2026-01-20
ACTION-1
RayzeBio, Inc.
Phase 3
Recruiting
288 enrolled
NCT00412061
2014-11-21
RADIANT-2
Novartis
Phase 3
Completed
429 enrolled
13 charts